Malaria, Vivax

Displaying 1 - 6 of 6CSV
Commons, R. J., Rajasekhar, M., Allen, E. N., Yilma, D., Chotsiri, P., Abreha, T., Adam, I., Awab, G. R., Barber, B. E., Brasil, L. W., Chu, C. S., Cui, L., Edler, P., Gomes, M. do S. M., Gonzalez‑Ceron, L., Grigg, M. J., Hamid, M. M. A., Hwang, J., Karunajeewa, H., … Woyessa, A. (2024). Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis. The Lancet Child & Adolescent Health, 8(11), 798–808. https://doi.org/10.1016/s2352-4642(24)00210-4
Publication Date
Columbia Affiliation
Mehdipour, P., Rajasekhar, M., Dini, S., Zaloumis, S., Abreha, T., Adam, I., Awab, G. R., Baird, J. K., Brasil, L. W., Chu, C. S., Cui, L., Daher, A., do Socorro M Gomes, M., Gonzalez‑Ceron, L., Hwang, J., Karunajeewa, H., Lacerda, M. V. G., Ladeia-Andrade, S., … Leslie, T. (2023). Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. Malaria Journal, 22(1). https://doi.org/10.1186/s12936-023-04725-w
Publication Date
Columbia Affiliation
Rajasekhar, M., Simpson, J. A., Ley, B., Edler, P., Chu, C. S., Abreha, T., Awab, G. R., Baird, J. K., Bancone, G., Barber, B. E., Grigg, M. J., Hwang, J., Karunajeewa, H., Lacerda, M. V. G., Ladeia-Andrade, S., Llanos-Cuentas, A., Pukrittayakamee, S., Rijal, K. R., Saravu, K., … Woyessa, A. (2024). Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis. The Lancet Infectious Diseases, 24(2), 184–195. https://doi.org/10.1016/s1473-3099(23)00431-0
Publication Date
Columbia Affiliation
Commons, R. J., Rajasekhar, M., Edler, P., Abreha, T., Awab, G. R., Baird, J. K., Barber, B. E., Chu, C. S., Cui, L., Daher, A., Gonzalez-Ceron, L., Grigg, M. J., Hwang, J., Karunajeewa, H., Lacerda, M. V. G., Ladeia-Andrade, S., Lidia, K., Llanos-Cuentas, A., Longley, R. J., … Woyessa, A. (2024). Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. The Lancet Infectious Diseases, 24(2), 172–183. https://doi.org/10.1016/s1473-3099(23)00430-9
Publication Date
Columbia Affiliation
de Vries, L. E., Jansen, P. A. M., Barcelo, C., Munro, J., Verhoef, J. M. J., Pasaje, C. F. A., Rubiano, K., Striepen, J., Abla, N., Berning, L., Bolscher, J. M., Demarta-Gatsi, C., Henderson, R. W. M., Huijs, T., Koolen, K. M. J., Tumwebaze, P. K., Yeo, T., Aguiar, A. C. C., Angulo-Barturen, I., … Dechering, K. J. (2022). Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-29688-5
Publication Date
Christensen, P., Racklyeft, A., Ward, K. E., Matheson, J., Suwanarusk, R., Chua, A. C. Y., Kaneko, O., Aung, H. L., Rénia, L., Amanzougaghene, N., Magneron, V., Lemaitre, J., Le Grand, R., Kyle, D., Bifani, P., Cook, G. M., Snounou, G., & Russell, B. (2022). Improving in vitro continuous cultivation of Plasmodium cynomolgi, a model for P. vivax. Parasitology International, 89, 102589. https://doi.org/10.1016/j.parint.2022.102589
Publication Date